IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients

Détails

ID Serval
serval:BIB_396013D3B27E
Type
Actes de conférence (partie): contribution originale à la littérature scientifique, publiée à l'occasion de conférences scientifiques, dans un ouvrage de compte-rendu (proceedings), ou dans l'édition spéciale d'un journal reconnu (conference proceedings).
Sous-type
Poster: résume de manière illustrée et sur une page unique les résultats d'un projet de recherche. Les résumés de poster doivent être entrés sous "Abstract" et non "Poster".
Collection
Publications
Institution
Titre
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients
Titre de la conférence
Annual Meeting of the Swiss Society of Rheumatology
Auteur⸱e⸱s
Aubry-Rozier B., Stoll D., Krieg M.A., Lamy O., Hans D.
Adresse
Fribourg, Switzerland, September 8-10, 2010
ISBN
1424-3997
Statut éditorial
Publié
Date de publication
2010
Peer-reviewed
Oui
Volume
140
Série
Swiss Medical Weekly
Pages
5S
Langue
anglais
Résumé
Introduction: Vertebral fracture is one of the major osteoporotic
fractures which are unfortunately very often undetected. In addition, it
is well known that prevalent vertebral fracture increases dramatically
the risk of future additional fracture. Instant Vertebral Assessment (IVA)
has been introduced in DXA device couple years ago to ease the
detection of such fracture when routine DXA are performed. To
correctly use such tool, ISCD provided clinical recommendation on
when and how to use it. The aim of our study was to evaluate the ISCD
guidelines in clinical routine patients and see how often it may change
of patient management.
Methods: During two months (March and April 2010), a medical
questionnaire was systematically given to our clinical routine patient to
check the validity of ISCD IVA recommendations in our population. In
addition, all women had BMD measurement at AP spine, Femur and
1/3 radius using a Discovery A System (Hologic, Waltham, USA). When
appropriate, IVA measurement had been performed on the same DXA
system and had been centrally evaluated by two trained Doctors for
fracture status according to the semi-quantitative method of Genant.
The reading had been performed when possible between L5 and T4.
Results: Out of 210 women seen in the consultation, 109 (52%)
of them (mean age 68.2 ± 11.5 years) fulfilled the necessary criteria to
have an IVA measurement. Out of these 109 women, 43 (incidence
39.4%) had osteoporosis at one of the three skeletal sites and 31
(incidence 28.4%) had at least one vertebral fracture. 14.7% of women
had both osteoporosis and at least one vertebral fracture classifying
them as "severe osteoporosis" while 46.8% did not have osteoporosis
nor vertebral fracture. 24.8% of the women had osteoporosis but no
vertebral fracture while 13.8% of women did have osteoporosis and
vertebral fracture (clinical osteoporosis).
Conclusion: In conclusion, in 52% of our patients, IVA was needed
according to ISCD criteria. In half of them the IVA test influenced of
patient management either by changing the type of treatment of simply
by classifying patient as "clinical osteoporosis". IVA appears to be an
important tool in clinical routine but unfortunately is not yet very often
used in most of the centers.
Création de la notice
07/03/2011 16:07
Dernière modification de la notice
20/08/2019 14:28
Données d'usage